// App-Quantinova.ai

448 : Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards

Researchers

Presenter

  • Michael D Wiese

Principal Investigators

  • Robert Metcalf

  • Mihir D Wechalekar

  • Llew Spargo

  • Leah McWilliams

  • Michael James

  • Catherine Hill

  • Susanna Proudman

Medical Centers

  • School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.

  • Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia

  • Royal Adelaide Hospital, Adelaide, Australia

  • Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia

  • School of Medicine, University of Adelaide, Adelaide, Australia

  • The Queen Elizabeth Hospital Campus, CALHN, Woodville, Australia

  • University of Adelaide, Adelaide, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • HWA-486

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved